NEW YORK (
) hit a new 52-week high Monday as it is currently trading at $28.03, above its previous 52-week high of $28 with 148,940 shares traded as of 3:19 p.m. ET. Average volume has been 145,400 shares over the past 30 days.
Amsurg has a market cap of $807.9 million and is part of the
industry. Shares are up 5.6% year to date as of the close of trading on Friday.
AmSurg Corp., through its subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers (ASC) in partnership with physicians in the United States. The company has a P/E ratio of 16.4, below the average health services industry P/E ratio of 17 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Amsurg as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in stock price during the past year and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our